IV Infusion Bottle Seals and Caps Market is segmented By Product (PP Caps, Rubber Seals), By Neck Size (Up to 20 mm, 21-28 mm, 29-32 mm, Above 32 mm), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030.
IV Infusion Bottle Seals and Caps Market is predicted to reach a high CAGR of 2.6% during the forecast period (2023-2030). One of the most significant components of the IV bag system is the IV infusion bottle. Its purpose is to offer sterile, convenient, and hygienic packing for the liquids required for IV medication administration. If the IV infusion bottle seals and caps get contaminated or lose their seal, they can be simply replaced. All bottles should be regularly checked for damage or deterioration due to light, heat, moisture, light, and oxygen exposure. Seals come in a variety of sizes, shapes, and colors. They can have a single, double, or snap-lock and be magnetic, water-resistant, airtight, laminated, or injection-studded. The type of seal utilized will be determined by the product requirements provided by the manufacturer. Some IV infusion bottle seals and caps also have a water reservoir, making them extremely portable and simple to use. These bottles can also be used to hold injector syringes and needles. They're frequently utilized to keep IV fluids like blood and serum safe.
Market Dynamics
The IV Infusion bottle seals & caps market is predicted to increase in response to the rising prevalence of chronic diseases.
The rising global burden of chronic diseases is likely to boost demand for IV infusion products, propelling the market forward throughout the forecast period. According to a World Health Organization (WHO) report from 2017, chronic diseases are the leading cause of disability worldwide.
Furthermore, according to World Federation of Hemophilia (WFH) figures from 2018, approximately 440,000 persons worldwide had hemophilia, with around 173,000 people diagnosed with hemophilia A or B in 2017. The World Health Organization (WHO) estimates 18.1 million cancer cases and 9.6 million deaths occurred worldwide in 2018. Several variables, including population expansion and the aging population, are contributing to the rising cancer burden.
Over the forecast period, rising private equity firm investments are likely to boost the market growth.
Many private equity firms are putting money into the packaging sector, which is projected to enhance the market's product offers. For example, Creador, a Malaysian private equity group, invested US$ 34.1 million in Shriji Polymers (India) Ltd., a manufacturer of high-density polyethylene bottles, polypropylene caps, and other specialty goods, in August 2020. Shriji's product lines and global footprint are projected to grow due to the transaction, and Creador now has a minority position in Shriji Polymers.
The increasing use of IV bags to replace traditional infusion bottles has lowered the demand for infusion bottles, which is projected to slow the growth of the IV infusion bottle seals and caps market throughout the forecast period.
COVID-19 Impact Analysis
The coronavirus (COVID-19) epidemic and worldwide lockdown have impacted the financial health of enterprises in many sectors. The healthcare sector has been put under financial strain due to the pandemic's lockdown in several countries.
Furthermore, in the event of a pandemic, regulatory approval for IV infusion therapy will likely propel the worldwide IV infusion bottle seals & caps market forward over the forecast period. The US Food and Drug Administration (FDA) approved blanket COVID-19 Emergency Use Authorization for IV infusion pumps and accessories required for COVID-19 patients' infusion therapy in May 2020. The approval also covers IV administration sets, containers and catheters, as well as patient-controlled painkiller pumps.
Segment Analysis
The IV infusion bottle seals & caps market is classified into PP caps and rubber seals by product.
PP caps segment is expected to be the dominant type during the forecast period (2021-2028)
The introduction of cutting-edge technology in the pharmaceutical packaging business, together with stringent packaging safety standards, is expected to drive demand for PP caps in the near future. PP caps are also increasingly being utilized to seal IV infusion bottles because of their ability to preserve their shape and resistance to breakage and bending.
Pharmaceutical packaging businesses have established the most reliable and stable neck size for 21-28 mm caps. Furthermore, the size mentioned above PP provide increased gripping capabilities and preserve product integrity – a key feature that will likely affect demand for 21-28 mm neck-sized caps shortly.
IV Infusion Bottle Seals and Caps Market
|
Metrics |
Details |
|
Market CAGR |
2.6% |
|
Segments Covered |
By Product, By Neck Size, and By Region |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
|
Fastest Growing Region |
Asia Pacific |
|
Largest Market Share |
North America |
Geographical Analysis
The global IV infusion bottle seals & caps market is centered in North America.
North America's market growth is being driven by a robust healthcare system, a strong pursuit of optimal medical polymers, and increased advancements in pharmaceutical plastic bottles. By adopting an outsourcing model, leading players in the IV infusion bottle seals and caps market are trying to extend their global footprint while maximizing their ROI. North American pharmaceutical packaging companies partner with East Asian and South Asian enterprises to lower their operating, logistics, and transportation expenses.
However, some of the most well-known pharmaceutical packaging companies are shifting their operations to nations like China. Furthermore, East Asia's relatively inexpensive raw material costs draw investors from established brands looking to expand their global footprint.
Competitive Landscape
Cardinal Health, Dätwyler Holding Inc., Medline Industries, Inc., B. Braun Medical Inc., RENOLIT SE, Winfield Laboratories Inc., PRASAD MEDITECH, Wuxi Qitian Medical Technology Co., Ltd., Biomed, and Polymedicure are some of the major players in the global IV infusion bottle seals & caps market.
Cardinal Health
Overview: Cardinal Health, Inc. is a pharmaceutical distributor, a global manufacturer and distributor of medical and laboratory goods, and a provider of performance and data solutions for healthcare institutions, with headquarters in Dublin, Ohio.
Cardinal Health seizes the chance to handle healthcare's most complex challenges with its 50 years of experience, nearly 48,000 workers, and operations in more than 40 countries. It services nearly 90% of hospitals in the United States and more than 29,000 pharmacies and 10,000 specialized physician offices and clinics.
Product Portfolio: It provides industry expertise as well as a growing array of safe, effective products that help to enhance quality, cut costs, and simplify processes. The industry's trusted regulatory expertise, insights, and infrastructure assist manufacturers and suppliers in developing and sourcing goods that fulfill the demand for cost-effective, complete healthcare solutions.
Key Developments: In 2021, Cardinal Health stated that its agreements to distribute medications to retail pharmacies and distribution centers with CVS Health had been extended until June 30, 2027.
The global IV infusion bottle seals & caps report would provide access to an approx. 53 market data table, 43 figures and 180 pages.
